Please sign in to follow a disease.
Primary generalized tonic-clonic seizures
Clinical trials for Primary generalized tonic-clonic seizures explained in plain language.
Never miss a new study
Get alerted when new Primary generalized tonic-clonic seizures trials appear
Sign up with your email to follow new studies for Primary generalized tonic-clonic seizures, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New seizure drug shows promise in late-stage trial
Disease control Recruiting nowThis study tests whether XEN1101, taken alongside current seizure medications, can reduce the number of generalized tonic-clonic seizures (convulsions affecting the whole body). About 160 people aged 12 and older with these seizures will receive either XEN1101 or a placebo for se…
Matched conditions: PRIMARY GENERALIZED TONIC-CLONIC SEIZURES
Phase 3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Real-world safety of fycompa injection under the microscope for epilepsy patients
Knowledge-focused Recruiting nowThis study tracks the safety of Fycompa injection in people with epilepsy who have partial-onset seizures (age 4 and older) or primary generalized tonic-clonic seizures (age 12 and older). Researchers will record any side effects and measure drug levels in children aged 4 to 12. …
Matched conditions: PRIMARY GENERALIZED TONIC-CLONIC SEIZURES
Sponsor: Eisai Co., Ltd. • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC